DMII Drugs Made In America Acquisition II Corp. - Ordinary Shares

10.19USD0.00%Mkt Cap: 649.10M $P/E: 35.14

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other si…

Key Statistics

Company
Market Cap649.10M USD
Enterprise Value649.38M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)4.19M USD
Revenue/Share—
Last Price10.19 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryUS
SectorFinancial Services
IndustryShell Companies
ISIN—
Valuation
P/E (Trailing)35.14
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-36.26
EPS (TTM)0.30
EPS (Forward)—
52W Range
9.86070% of range10.33
52W High10.33 USD
52W Low9.860 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE0.86%
ROA0.83%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.02M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt275.03K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.34
Quick Ratio0.27
Book Value/Sh-0.28 USD
Cash/Share0.0030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.63.70M
Float54.01M
Insiders15.21%
Institutions72.88%
Short Interest
Short Ratio2.2d
Short % Float0.21%
Short % Out.0.20%
Shares Short126.14K
Short (prev mo.)121.96K
Technical
SMA 5010.14 (+0.5%)
SMA 20010.04 (+1.5%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)66.89K
Avg Vol (10d)23.52K
Technical Indicators
RSI (14)64.9
MACD0.0101
MACD Signal0.0089
MACD Hist.+0.0012
BB Upper10.19 USD
BB Middle10.17 USD
BB Lower10.15 USD
BB Width0.44%
ATR (14)0.0178 USD
Vol Ratio (20d)0.34x